Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Edesa Biotech Inc (EDSA)

Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference GlobeNewswire - Tue May 19, 8:15AM CDT

Oral presentation at ERA Congress, the flagship European nephrology meeting Company expects to present additional data TORONTO, May 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:...

EDSA : 10.46 (-3.77%)
Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results GlobeNewswire - Thu May 14, 3:30PM CDT

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases,...

EDSA : 10.46 (-3.77%)
Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit GlobeNewswire - Tue Mar 31, 3:20PM CDT

TORONTO, March 31, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases,...

EDSA : 10.46 (-3.77%)
Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment GlobeNewswire - Thu Mar 26, 8:15AM CDT

TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases,...

EDSA : 10.46 (-3.77%)
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study GlobeNewswire - Tue Feb 24, 8:15AM CST

Results in a population of 278 patients affirm statistically significant mortality reductions Benefits observed across severity groups and in subjects with serious comorbidities Company files provisional...

EDSA : 10.46 (-3.77%)
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results GlobeNewswire - Fri Feb 13, 3:20PM CST

TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases,...

EDSA : 10.46 (-3.77%)
Edesa Biotech Reports Fiscal Year 2025 Results GlobeNewswire - Fri Dec 12, 2025

TORONTO, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases,...

EDSA : 10.46 (-3.77%)
Interest Rate Decisions Due on Both Sides of Border Next Week Baystreet - Mon Dec 8, 2025

Monday U.S. Featured Earnings Oracle Corp. (NYSE:ORCL) (Q2) EPS for $1.29, compared ...

YEXT : 3.68 (+2.51%)
AVGO : 414.14 (-0.10%)
JOUT : 43.56 (+1.47%)
ORCL : 192.08 (+1.22%)
EDSA : 10.46 (-3.77%)
TOL : 134.33 (-0.13%)
CIEN : 583.74 (-0.59%)
COST : 1,028.24 (-2.11%)
FERG : 223.31 (-0.19%)
AZO : 3,406.50 (-0.92%)
ADBE : 244.76 (+0.27%)
SNPS : 524.74 (+4.12%)
Interest Rate Decisions Due on Both Sides of Border Next Week Baystreet - Mon Dec 8, 2025

Monday U.S. Featured Earnings Oracle Corp. (NYSE:ORCL) (Q2) EPS for $1.29, compared ...

YEXT : 3.68 (+2.51%)
AVGO : 414.14 (-0.10%)
JOUT : 43.56 (+1.47%)
ORCL : 192.08 (+1.22%)
EDSA : 10.46 (-3.77%)
TOL : 134.33 (-0.13%)
CIEN : 583.74 (-0.59%)
COST : 1,028.24 (-2.11%)
FERG : 223.31 (-0.19%)
AZO : 3,406.50 (-0.92%)
ADBE : 244.76 (+0.27%)
SNPS : 524.74 (+4.12%)
Edesa Biotech Announces Upcoming Conference Schedule GlobeNewswire - Fri Oct 31, 2025

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases,...

EDSA : 10.46 (-3.77%)

Barchart Exclusives

Short Sellers Keep Placing Their Bets Against Micron Stock. Why They Think MU Will Stumble Soon. Barchart - 58 minutes ago
Even as Micron rides the AI memory boom to historic highs, short sellers are piling in bearish bets, wagering the semiconductor rally may be overheating. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.